Yiran Tao

PR China
Zhengzhou, Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Advancements and perspectives of RBX2 as a molecular hallmark in cancer.

Advancements and perspectives of RBX2 as a molecular hallmark in cancer.

Journal: Gene

Published: June 26, 2023

Advances in research on schistosomiasis and toxoplasmosis in China: A bibliometric analysis of Chinese academic journals published from 1980 to 2021.

Advances in research on schistosomiasis and toxoplasmosis in China: A bibliometric analysis of Chinese academic journals published from 1980 to 2021.

Journal: Acta tropica

Published: June 05, 2022

The role of ubiquitin-specific peptidases in glioma progression.

The role of ubiquitin-specific peptidases in glioma progression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 07, 2021

Characterization of N-linked intact glycopeptide signatures of plasma IgGs from patients with prostate carcinoma and benign prostatic hyperplasia for diagnosis pre-stratification.

Characterization of N-linked intact glycopeptide signatures of plasma IgGs from patients with prostate carcinoma and benign prostatic hyperplasia for diagnosis pre-stratification.

Journal: The Analyst

Published: June 23, 2020

Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.

Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.

Journal: MedComm

Published: May 20, 2020

Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.

Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.

Journal: European journal of medicinal chemistry

Published: December 29, 2019

Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.

Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.

Journal: Future medicinal chemistry

Published: December 17, 2019

Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.

Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.

Journal: European journal of medicinal chemistry

Published: February 01, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026